10-Q: Jushi Holdings Inc. Q2 2026 Financial Update

Jushi Holdings Inc. reports a 10% revenue increase in Q2 2026 driven by wholesale growth and retail expansion, despite ongoing price compression.

Summary

• Jushi Holdings Inc. reported a 10% increase in total revenue for the three months ended June 30, 2026, reaching $71.3 million, up from $65.0 million in the prior year period.
• Wholesale revenue saw a significant jump of 68%, while retail revenue grew by 4%.
• Gross profit increased by 9% to $31.5 million, with gross profit margin remaining stable at 44%.
• Operating expenses rose by 22% to $30.8 million, largely due to impairment charges and increased operational costs.
• The company reported a net loss of $7.3 million for the quarter, an improvement from a $12.3 million net loss in the same period last year.
• Cash flow from operations improved significantly, showing $9.4 million provided by operating activities for the six months ended June 30, 2026, compared to $5.6 million in the prior year.
• The company completed a refinancing of its debt, issuing a $160 million term loan.
• The federal rescheduling of cannabis to Schedule III is expected to provide tax benefits, with a discrete income tax benefit of $6.4 million recognized in the quarter.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive, with revenue growth and improved operational cash flow being key strengths, partially offset by continued net losses and rising operating expenses.

Positives

• Total revenue increased by 10% to $71.3 million for the quarter.
• Wholesale revenue grew by 68% to $9.4 million.
• Retail revenue increased by 4% to $61.9 million, supported by new store openings and increased unit sales.
• Gross profit increased by 9% to $31.5 million, with margins stable at 44%.
• Net loss improved to $7.3 million from $12.3 million in the prior year's quarter.
• Cash flow from operations improved by 68% to $9.4 million for the six-month period.
• The company recognized a $6.4 million discrete income tax benefit due to the federal rescheduling of cannabis.
• The company is in compliance with its financial covenants for the 2026 Term Loan and mortgage loans.

Negatives

• Operating expenses increased by 22% to $30.8 million, driven by impairment charges and other operational costs.
• Retail revenue growth was tempered by price compression and increased promotional activity in key markets like Illinois, Pennsylvania, and Massachusetts.
• The company reported a net loss of $7.3 million for the quarter.
• The company faces ongoing competition and pricing pressures in its operating markets.
• The company has a significant liability for unrecognized tax benefits totaling $193.9 million.
• The company's operations remain subject to federal illegality of cannabis, posing risks of asset forfeiture and regulatory action.
• The company's stock price experienced volatility, impacting the fair value of derivative warrants.
• The company has a substantial accumulated deficit of $654.4 million.

Risks

• Continued federal illegality of cannabis in the U.S. poses risks of asset forfeiture and regulatory action.
• The company faces significant competition and pricing pressures in its operating markets.
• The rescheduling of cannabis to Schedule III is subject to potential legal challenges, which could impact tax benefits.
• The company's ability to realize the anticipated benefits of Virginia's transition to an adult-use cannabis market is uncertain.
• The company may not be able to complete the proposed continuance from British Columbia to Nevada or realize its anticipated benefits.
• The company has a substantial amount of debt, including a $160 million 2026 Term Loan.
• The company's operations are subject to evolving state and local regulations, with potential for fines or loss of permits.
• The company has a history of operating losses and negative operating cash flows.

Future Outlook

The company anticipates that the transition to an adult-use cannabis market in Virginia, scheduled to begin July 1, 2027, presents a potential opportunity for revenue growth. The company believes its existing cash and cash equivalents, along with cash from operations, will be sufficient to meet its working capital and capital expenditure needs for at least the next twelve months. The company may also consider opportunistic capital raising or refinancing transactions.

Management Comments

• The shareholders voted in favor of a proposed arrangement involving the continuance of the Company out from British Columbia and domestication in Nevada.
• The transition to an adult-use market in Virginia is expected to expand our customer base and result in increased demand for our products.
• We believe that our business activities are compliant with applicable state and local laws in the U.S., but compliance with state and local cannabis laws would not necessarily provide a defense to any federal proceeding that may be brought against us.

Industry Context

StockSavvy.ai notes that Jushi Holdings Inc. is operating within the highly dynamic and evolving U.S. cannabis industry. The recent federal rescheduling of cannabis to Schedule III is a significant development, potentially easing tax burdens under Section 280E for qualifying medical cannabis operations, though its full impact and retroactivity remain subject to guidance and potential legal challenges. The company's revenue growth, particularly in wholesale, reflects increasing market maturity and operational efficiencies, while retail growth is supported by expansion into new markets and new store openings. However, persistent price compression and competition highlight the ongoing challenges in the sector.

Comparison to Industry Standards

• Jushi's gross profit margin of 44% is competitive within the U.S. cannabis retail sector, where margins can range from 30% to 60% depending on the state and operational model.
• The company's net loss of $7.3 million for the quarter, while significant, represents an improvement from the prior year, aligning with a trend seen in some multi-state operators (MSOs) focusing on profitability over aggressive expansion.
• The increase in wholesale revenue is a positive indicator, as many MSOs are seeking to diversify revenue streams beyond retail, a strategy also pursued by companies like Curaleaf and Green Thumb Industries.
• The company's focus on limited license states, such as Virginia and Ohio, is a common strategy among MSOs aiming to mitigate intense competition found in more open markets.

Corporate Governance

Legal Proceedings

• MJs Market Matter: Complaint filed alleging violations of antitrust and consumer protection acts related to the Nature's Remedy of Massachusetts acquisition.
• Sammartino Matter: Dispute over alleged breaches of a merger and membership interest purchase agreement, with the company electing to offset damages against promissory notes.
• Pacific Collective Matter: Lawsuit alleging breach of a commercial property lease; an appeal by Pacific Collective is pending.

Related Party Transactions

• Participation in the 2026 Term Loan by entities controlled by the CEO and a significant equity holder.
• Promissory notes payable to Sammartino, a former owner, with repayment contingent on legal judgments.

Stakeholder Impact

• Shareholders: Potential benefits from corporate restructuring (Nevada continuance) and improved financial performance, but ongoing net losses and legal risks persist.
• Employees: Increased operational costs and potential restructuring impacts, though expansion in certain markets may create opportunities.
• Suppliers: Continued demand for cannabis products and inputs, with potential for improved quality and production volumes.
• Creditors: Refinancing of debt provides some stability, but the company's leverage remains a consideration.

Next Steps

• The company is awaiting DEA registration for its medical and dual-use operations following the federal rescheduling of cannabis.
• The company expects to capitalize on Virginia's transition to an adult-use cannabis market, with sales scheduled to begin July 1, 2027.
• The company plans to continue managing its debt obligations and may explore opportunistic capital raising or refinancing.
• The company will continue to monitor and adapt to evolving state and federal cannabis regulations.

Key Dates

Recommendation

The company shows signs of operational improvement with revenue growth and better cash flow, and the potential tax benefits from cannabis rescheduling are positive. However, persistent net losses, significant debt, ongoing legal proceedings, and the inherent risks of the cannabis industry warrant a cautious 'hold' stance until a clear path to sustained profitability is demonstrated.

Keywords

Jushi Holdings, Cannabis Operator, Quarterly Report, Revenue Growth, Wholesale Cannabis, Retail Cannabis, Schedule III Rescheduling, Form 10-Q